Pada tanggal 30 Juli 2019, melalui Surat Pernyataan Pendaftaran No.
234/IRR-Adm/Jkt/VI/2019, Entitas telah menawarkan sahamnya kepada masyarakat melalui pasar modal sejumlah 400.000.000 lembar saham dengan nilai nominal Rp 50,- per saham dengan harga penawaran Rp 374,- per saham.
Pada tanggal 30 September 2019, berdasarkan Surat Keputusan Dewan Komisioner Otoritas Jasa Keuangan Kepala Eksekutif Pengawas Pasar Modal No. S-145/D.04/2019, Entitas telah memperoleh Surat Pemberitahuan Efektifnya Pernyataan Pendaftaran.
282,002,736,385
135,933,624,661
Pada tanggal 24 Juli 2019, Berdasarkan Akta pernyataan Keputusan Para Pemegang Saham Perseroan No 190, modal dasar perseroan ditingkatkan dari Rp 82.000.000.000,- menjadi Rp 240.000.000.000,-, dengan modal ditempatkan dan disetor dari Rp 20.500.000.000,- menjadi Rp 60.000.000.000,- yang terbagi atas 1.200.000.000 lembar saham yang masing-masing saham bernilai nominal Rp 50,-. Akta tersebut telah mendapatkan pengesahan berdasarkan Keputusan Menteri Hukum dan Hak Asasi Manusia Republik Indonesia Nomor AHU-0119447.AH.01.11.Tahun 2019 tanggal 25 Juli 2019.
Berdasarkan kegiatan Penawaran Umum Perdana Saham atau Emisi Saham kepada masyarakat (Go Public), entitas mencatat adanya kelebihan penerimaan diatas nominal saham sebagai berikut:
135,933,624,661
Based on the activities of the Initial Public Offering or Stock Issuance to the public (Go Public), the entity records the excess revenue above the share nominal as follows:
December 31, 2020
Saldo Laba Tahun Lalu 79,689,542,539 34,560,705,020 Retained Earnings Prior Years
Penyesuaian Periode Lalu Adjustment Prior Year
- Pembentukan Saldo Awal CKPN - (7,714,713,887) Establishment of CKPN Initial Balance
-- Penyesuaian Saldo Awal Deferred Tax Beginning
-Pajak Tangguhan - 1,665,842,505 Balance Adjustment
Dividen (18,000,000,000) (9,344,283,600) Dividend
Laba Tahun Berjalan 84,923,165,373 60,521,992,500 Net Income Current Years Jumlah Saldo Laba 146,612,707,912 79,689,542,538 Total Retained Earning
22. PENDAPATAN USAHA 22.REVENUE
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Penjualan Barang Dagangan 1,086,338,248,099 141,056,593,253 Sales of Merchandise Jumlah Pendapatan Usaha 1,086,338,248,099 141,056,593,253 Total Revenue
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Pihak Ketiga Third Parties
UTD PMI Provinsi DKI Jakarta - 17,810,252,636 UTD PMI Provinsi DKI Jakarta PT Dharma Mitra Abadi - 16,679,601,454 PT Dharma Mitra Abadi Direktorat Tata Kelola Obat Publik - Direktorat Tata Kelola Obat Publik
dan Perbekalan Kesehatan 23,723,078,019 dan Perbekalan Kesehatan
PT Semesta Medika Indonesia - 30,191,613,636 PT Semesta Medika Indonesia PT. Sinergi Utama Sejahtera 349,671,681,818 - PT. Sinergi Utama Sejahtera
Jumlah 349,671,681,818 88,404,545,745 Total
Berdasarkan Berita Acara Rapat Umum Pemegang Saham Tahunan Perseroan Terbatas PT Itama Ranoraya Tbk No. 136 Tanggal 22 April 2021, Entitas memutuskan untuk membagikan dividen sebesar Rp 12,- per saham sesuai dengan proporsi kepemilikan saham yang dimiliki, sedangkan sisa saldo laba Entitas disisihkan dan dibukukan sebagai Dana Cadangan.
Based on the Minutes of the Annual General Meeting of Shareholders of the Limited Company P136173 Dated April 22, 2021 the Entity decided to distribute a dividend of Rp 6,- per share according to the proportion of share ownership held, while the remaining balance of the Entity's profit balance was set aside and recorded as a General Reserve.
Rincian pelanggan dengan nilai pendapatan melebihi 10% dari total pendapatan sebagai berikut:
The details of customers whose revenue value exceeded 10% of the total revenue are as follows:
(Disajikan dalam rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
22. PENDAPATAN USAHA - Lanjutan 22.REVENUE - Continued
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Pihak Ketiga Third Parties
UTD PMI Provinsi DKI Jakarta 0.00% 13.11% UTD PMI Provinsi DKI Jakarta
PT Dharma Mitra Abadi 0.00% 12.28% PT Dharma Mitra Abadi
Direktorat Tata Kelola Obat Publik Direktorat Tata Kelola Obat Publik
dan Perbekalan Kesehatan 0.00% 17.46% dan Perbekalan Kesehatan
PT Semesta Medika Indonesia 0.00% 22.23% PT. Sinergi Utama Sejahtera
PT. Sinergi Utama Sejahtera 32.00% 0.00% PT. Sinergi Utama Sejahtera
Jumlah 32.00% 65.08% Total
23. BEBAN POKOK PENJUALAN 23.COST OF SALES
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Persediaan Awal 20,153,594,062 11,159,437,076 Beginning Balance
Pembelian Bersih 1,087,718,271,810 111,374,638,334 Nett Purchase
Persediaan Akhir (222,437,173,117) (9,246,466,063) Ending Balance
Jumlah Barang Terjual 885,434,692,755 113,287,609,347 Total Sold Items
Beban Overhead Overhead Expenses
Beban Service Mesin Abbott 11,050,532,789 2,454,375,000 Services Abbott Mechine Beban Packing & Overhead 1,787,837,797 133,400,522 Packing and Overhead
Jumlah Beban Overhead 12,838,370,586 2,587,775,522 Total Overhead Expenses
Jumlah Beban Pokok Penjualan 898,273,063,341 115,875,384,869 Total Cost of Sales
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Pihak Ketiga Third Parties
PT Abbott Products Indonesia - 45,760,304,200 PT Abbott Products Indonesia PT Oneject Indonesia - 25,844,809,362 PT Oneject Indonesia PT Green Medica - 29,134,907,159 PT Green Medica PT Alere Health 840,853,982,241 - PT Alere Health
Jumlah 840,853,982,241 100,740,020,721 Total
Persentase pelanggan dengan nilai pendapatan melebihi 10% dari total pendapatan sebagai berikut:
The percentage of customers whose revenue value exceeded 10% of the total revenue are as follows:
Rincian pemasok dengan nilai pembelian melebihi 10% dari total pembelian sebagai berikut:
The details of suppliers whose purchase value exceeded 10% of the total purchase are as follows:
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Pihak Ketiga Third Parties
PT Abbott Products Indonesia 0.00% 41.09% PT Abbott Products Indonesia
PT Oneject Indonesia 0.00% 23.21% PT Oneject Indonesia
PT Green Medica 0.00% 26.16% PT Green Medica
PT Alere Health 66.05% 0.00% PT Alere Health
Jumlah 0.00% 90.45% Total
24. BEBAN OPERASIONAL 24.OPERATING EXPENSES
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Beban Gaji 13,667,390,299 5,640,622,907 Salaries Expense
Beban Pengiriman 5,002,742,055 1,479,214,381 Shipping Expense Beban Pemeliharaan 1,678,458,711 263,945,424 Maintenance Expenses Beban Perjalanan Dinas 515,984,588 186,657,799 Official Travel Expenses Beban Rumah Tangga Kantor 876,058,708 398,064,176 Consumables Office Expense Beban Transportasi 664,674,317 216,135,412 Transportation Expenses Beban Software 96,420,364 140,769,529 Software Expenses Beban Sewa Bangunan 353,765,003 166,666,666 Building Rent Expenses Beban Imbalan Kerja 128,507,000 136,807,500 Employees Benefit Expense Beban Alat Tulis Kantor 252,697,759 53,794,505 Office Stationery Supplies Beban Komunikasi 162,233,556 88,951,170 Communications Expense Beban Upah - 4,550,000 Wages Expenses Beban Perijinan 306,667,382 114,883,745 Legal Expenses Beban Jamsostek 133,778,499 87,654,359 Jamsostek Expenses Beban Asuransi 285,759,035 47,645,240 Insurance Expenses Beban Management/Konsultan 2,694,969,285 875,619,578 Management/Consultants Expense Beban Personalia 181,488,652 33,480,008 HRD Expenses Beban Ekspedisi 11,261,400 46,401,294 Expeditions Expense Beban Pemasaran 36,459,518,703 28,475,000 Marketing Expenses Beban Penyusutan 3,343,138,770 2,030,968,022 Depreciation Expenses
Beban Pajak 45,388,653 9,450,000 Tax Expenses
Beban Adm Lain-lain 1,879,740,486 570,064,148 Others Administration Expense Beban Penyisihan Kerugian Piutang 1,000,000,000 - Allowance for Impairment Losses Expense Beban Pemasaran Lainnya 1,823,179,450 1,204,073,817 Others Marketing Expense
Jumlah Beban Operasional 71,563,822,675 13,824,894,680 Total Operating Expenses Persentase pemasok dengan nilai
pembelian melebihi 10% dari total pembelian sebagai berikut:
The percentage of suppliers whose purchase value exceeded 10% of the total purchase are as follows:
(Disajikan dalam rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
25. PENDAPATAN DAN (BEBAN) 25.OTHERS INCOME AND
LAIN-LAIN (EXPENSE)
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Pendapatan Lain-lain Other Income
Pendapatan Bunga Bank Bank Interest Income and
dan Jasa Giro 867,549,100 1,333,921,638 Current Account Services
Pendapatan Sewa 90,000,000 49,090,909 Rent Income
Pendapatan Deviden - 217,358,940 Dividend Pendapatan Lain-lain 207,438,186 307,450,000 Others Income
Jumlah Pendapatan Lain-lain 1,164,987,286 1,907,821,487 Total Others Income
Beban Lain-lain Other Expenses
Beban Bunga Pinjaman dan lainnya 8,454,847,592 1,023,854,219 Interest and Other Expenses Rugi Selisih Kurs 31,448 869,071,914 Loss on Foreign Exchange
Jumlah Beban Lain-lain 8,454,879,040 1,892,926,133 Total Other Expenses
Jumlah Pendapatan dan
(Beban) Lain-lain (7,289,891,754) 14,895,354 Total Others Income and (Expense)
26. LABA BERSIH PER SAHAM 26.NET INCOME PER SHARE
30 September 2021/ 30 September 2020/
September 30, 2021 September 30, 2020
Laba Bersih Tahun Berjalan 84,918,330,403 8,943,340,646 Net Income For The Years
Total Rata-rata Tertimbang Weighted Average Number of
Saham yang Beredar 1,600,000,000 1,486,377,600 Outstanding Shares Laba (Rugi) Bersih Per Saham 53 6 Net Income (Loss) Per Share
Alat kesehatan Produk Diagnostic Non Elektromedik
In Vitro/In Vitro Steril/Sterile
Diagnostic Non-Electromedical Lain-lain/ Total/
Product Medical Equipment Others Total
Pendapatan Usaha 1,047,178,710,477 29,684,505,817 9,475,031,802 1,086,338,248,096 Sales Beban Pokok Penjualan (865,008,318,135) (25,396,536,537) (7,868,208,669) (898,273,063,341) Cost Of Goods Sales Laba Kotor 182,170,392,342 4,287,969,280 1,606,823,133 188,065,184,755 Gross Profit
Beban Operasional (68,984,141,614) (1,955,502,086) (624,178,976) (71,563,822,676) Operating Income
Pendapatan dan Other Incomes and
(Beban) Lain-lain (7,027,110,994) (199,198,394) (63,582,366) (7,289,891,754) (Expenses) Laba Sebelum Pajak 106,159,139,734 2,133,268,800 919,061,791 109,211,470,325 Income Before Tax
Alat kesehatan Produk Diagnostic Non Elektromedik
In Vitro/In Vitro Steril/Sterile
Diagnostic Non-Electromedical Lain-lain/ Total/
Product Medical Equipment Others Total
Pendapatan Usaha 33,137,404,478 107,919,188,775 - 141,056,593,253 Sales Beban Pokok Penjualan (25,844,809,362) (90,030,575,507) - (115,875,384,869) Cost Of Goods Sales Laba Kotor 7,292,595,116 17,888,613,268 - 25,181,208,384 Gross Profit
Beban Operasional (11,360,439,798) (3,488,309,103) (14,848,748,901) Operating Income
Pendapatan dan Other Incomes and
(Beban) Lain-lain 794,723,654 244,025,921 1,038,749,575 (Expenses)
Laba Sebelum Pajak (3,273,121,028) 14,644,330,086 - 11,371,209,058 Income Before Tax
28. 28.
Mata Uang Asing / Setara Rupiah / Mata Uang Asing / Setara Rupiah / Foreign Currencies Rupiah Equivalent Foreign Currencies Rupiah Equivalent
Aset Assets
Kas dan Setara Kas Cash and Cash Equivalents
USD 3,238 46,319,244 3,290 46,319,160 USD
Aset Bersih Dalam Mata Net Assets In Foreign
Uang Asing 3,238 46,319,244 3,290 46,319,160 Currencies 30 September 2020/ September 30, 2020
ASET DAN LIABILITAS MONETER